ALLMedicine™ Struma Ovarii Center
Research & Reviews 88 results
https://doi.org/10.1111/jog.15619
The Journal of Obstetrics and Gynaecology Research; Yamauchi S, Kokabu T et. al.
Feb 23rd, 2023 - Malignant struma ovarii (MSO) is an extremely rare disease arising from struma ovarii. Preoperative diagnosis is still challenging due to the lack of criteria for imaging findings. Herein, we report a case of MSO with suggestive imaging findings f...
https://doi.org/10.1016/j.path.2022.09.008
Surgical Pathology Clinics; Smith LP, Brubaker LW et. al.
Feb 5th, 2023 - Thyroid carcinoma originating in struma ovarii comprises a small minority of all cases of struma ovarii. Given the rarity of this diagnosis, literature to guide evaluation and management is limited. The most common carcinoma originating from strum...
https://doi.org/10.1111/jog.15545
The Journal of Obstetrics and Gynaecology Research; Tamura N, Murakami K et. al.
Jan 13th, 2023 - Even though 95% of struma ovarii are benign, it is often overtreated because of the difficulty to distinguish it from malignancy. In this study, our aim was to evaluate the current state of the preoperative diagnosis and the selection of the surgi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829251
Medicine Shou L, Lu J et. al.
Jan 7th, 2023 - Follicular carcinoma originating from struma ovarii is a clinically rare low-grade malignant tumor. The pathological diagnosis of ovarian thyroid follicular carcinoma is predominantly based on the infiltrative growth and vascular involvement of tu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776615
Current Oncology (Toronto, Ont.); Giovannopoulou E, Saliaris K et. al.
Dec 23rd, 2022 - (1) Background: Highly differentiated follicular carcinoma of ovarian origin (HDFCO) is an extremely uncommon neoplasm, associated with struma ovarii. There are scarce cases reported in the literature and, subsequently, no reliable conclusions on ...
Clinicaltrials.gov 1 results
https://clinicaltrials.gov/ct2/show/NCT04053114
Aug 12th, 2019 - This is a retrospective cohort with collection of tissues samples (FFPE or frozen), including female patients >18-year-old treated in French between 2009 and 2016 for a thyroid carcinoma on struma ovarii. Clinical data and tissues will be centrali...